Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Ob/Gyn Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Ob/Gyn Other
    Blood Test Can Reduce Repeat Breast MRI in Women With Irregular Menstrual Cycles - (DGNews)
    Flibanserin Provides Multiple Benefits in Women With Low Sexual Desire: Presented at ESSM - (DGDispatch)
    ACOG Recommends Pap Tests for Cervical Cancer Screening Begin Later, With Lower Frequency - (DGNews)
    Flibanserin Effectively Treats Women With Low Libido: Presented at ESSM - (DGDispatch)
    US Panel Ups Age for Routine Breast Cancer Screening From 40 to 50 - (DGNews)

    News archive

     Recent webcasts/CME - Ob/Gyn Other
    • Expert Perspectives on Challenges, Controversies, and Opportunities in Ovarian Cancer Therapy: The Present and the Future
    • Taking Stock of the Current Research: Which New Therapies Are Showing Promise in Ovarian Cancer?
    • Q&A Lightning Round: Expert Opinions on Unanswered Questions and Controversies in Ovarian Cancer
    • Update on DVT and PE in OB Gyn/Ortho Patients
      Hypoactive Sexual Desire Disorder in Women: Implications for Family Practice

      Webcasts/CME archive

       Recent cases - Ob/Gyn Other
        Effects of Growth Hormone Reduction in a Patient with Polycystic Ovary Syndrome Complicated with Acromegaly
        Endometriosis Presenting as an Acute Groin Swelling: A Case Report
        Giant Ovarian Serous Cystadenoma in a Postmenopausal Woman: A Case Report
        Failure of Ultrasound to Diagnose a Giant Ovarian Cyst: A Case Report
        Female Sexual Dysfunction

        Cases archive
          




        my personal edition > ob/gyn other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Case Report Describes Fatal Motor Neuron Disease Following HPV Vaccination: Presented at ANA

        By Charlene Laino

        BALTIMORE, Md -- October 18, 2009 -- A case report suggests there may be a link between the vaccine against human papillomavirus (HPV) and a rapidly progressive, fatal, motor neuron disease, researchers reported here on October 13 at the American Neurological Association (ANA) 134th Annual Meeting.

        At her poster presentation, Catherine Lomen-Hoerth, MD, PhD, Director, ALS Center, University of California, San Francisco, Medical Center, said that a 14-year-old girl developed weakness in her left leg 2 months after her third and final Gardasil dose. The condition progressed rapidly: her muscle weakness relentlessly progressed to all her extremities and her muscles atrophied, she said. Despite treatment with aggressive immunosuppression, the girl died of respiratory failure 21 months after onset of symptoms.

        Dr. Lomen-Hoerth said the features suggest a clinical diagnosis of amyotrophic lateral sclerosis (ALS), but the disease progressed more quickly than typical for young ALS patients, she said.

        Postmortem examinations revealed widespread infiltration of T lymphocytes and macrophages in the grey and white matter at all levels of the spinal cord, Dr. Lomen-Hoerth continued. Additionally, there was widespread demyelination and severe loss of motor neurons.

        "We were surprised that the spinal cord was so inflammatory. That is very different from what we normally see in ALS," she said.

        "These pathological features support the temporal association of the clinical presentation and vaccination and provide supporting evidence that immune-mediated reactions in the nervous system are potential risks after Gardasil vaccination," she said.

        Still, "we don't know for sure if it's coincidence or if it's connected [to the vaccine]," Dr. Lomen-Hoerth said. "We hope that by raising awareness, we will become aware of any other cases," facilitating further study.

        Her team plans further study comparing the symptoms and pathological features of young adults with ALS who received the Gardasil vaccine to those who have not been vaccinated. "If the features are identical, then we'll know [the vaccine] is not the cause," Dr. Lomen-Hoerth says.

        Pam Eisele, a spokesperson for Merck & Co., which makes the vaccine, said the company cannot comment specifically on the case as it has not seen the data.

        "However, after carefully reviewing all the information available to us about reported adverse events, including reports of deaths, Merck does not believe these events have been caused by Gardasil," she said.

        [Presentation title: Demyelination and Severe Loss of Spinal Motor Neurons Following HPV Vaccination. Abstract WIP-19]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send